Arrowstreet Capital’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $99.8M | Buy |
1,104,218
+425,349
| +63% | +$39M | 0.05% | 309 |
|
|
2025
Q4 | $61M | Buy |
678,869
+205,257
| +43% | +$19.5M | 0.04% | 419 |
|
|
2025
Q3 | $46.7M | Sell |
473,612
-41,308
| -8% | -$4.09M | 0.03% | 471 |
|
|
2025
Q2 | $47M | Buy |
514,920
+42,196
| +9% | +$4.08M | 0.03% | 440 |
|
|
2025
Q1 | $53.5M | Buy |
472,724
+12,821
| +3% | +$1.37M | 0.04% | 357 |
|
|
2024
Q4 | $48.6M | Sell |
459,903
-109,685
| -19% | -$11.8M | 0.04% | 380 |
|
|
2024
Q3 | $61.5M | Sell |
569,588
-79,545
| -12% | -$8.68M | 0.05% | 295 |
|
|
2024
Q2 | $70.5M | Sell |
649,133
-247,505
| -28% | -$29.2M | 0.06% | 244 |
|
|
2024
Q1 | $118M | Sell |
896,638
-88,969
| -9% | -$11.1M | 0.11% | 172 |
|
|
2023
Q4 | $120M | Sell |
985,607
-45,008
| -4% | -$5.02M | 0.13% | 157 |
|
|
2023
Q3 | $116M | Sell |
1,030,615
-433,439
| -30% | -$55M | 0.14% | 147 |
|
|
2023
Q2 | $213M | Sell |
1,464,054
-83,993
| -5% | -$11.4M | 0.26% | 96 |
|
|
2023
Q1 | $200M | Sell |
1,548,047
-27,480
| -2% | -$3.45M | 0.26% | 99 |
|
|
2022
Q4 | $201M | Buy |
1,575,527
+289,193
| +22% | +$33.6M | 0.28% | 102 |
|
|
2022
Q3 | $134M | Buy |
1,286,334
+776,995
| +153% | +$85.3M | 0.2% | 121 |
|
|
2022
Q2 | $53.5M | Buy |
+509,339
| New | +$60.4M | 0.08% | 209 |
|
|
2022
Q1 | – | Sell |
-352,731
| Closed | -$43.5M | – | 1570 |
|
|
2021
Q4 | $43.5M | Sell |
352,731
-274,492
| -44% | -$35.9M | 0.05% | 310 |
|
|
2021
Q3 | $89.1M | Buy |
627,223
+109,553
| +21% | +$16.1M | 0.11% | 206 |
|
|
2021
Q2 | $80.8M | Buy |
+517,670
| New | +$83.9M | 0.1% | 222 |
|
|
2020
Q3 | – | Sell |
-22,351
| Closed | -$2.59M | – | 2553 |
|
|
2020
Q2 | $2.59M | Sell |
22,351
-300,976
| -93% | -$34.7M | ﹤0.01% | 1358 |
|
|
2020
Q1 | $31.7M | Buy |
+323,327
| New | +$42.4M | 0.09% | 202 |
|
|
2019
Q2 | – | Sell |
-151,293
| Closed | -$18.8M | – | 1748 |
|
|
2019
Q1 | $18.8M | Sell |
151,293
-7,842
| -5% | -$891K | 0.04% | 383 |
|
|
2018
Q4 | $16M | Buy |
159,135
+129,986
| +446% | +$14.6M | 0.04% | 334 |
|
|
2018
Q3 | $3.72M | Buy |
+29,149
| New | +$3.47M | 0.01% | 564 |
|
|
2018
Q2 | – | Sell |
-148,938
| Closed | -$15.8M | – | 1335 |
|
|
2018
Q1 | $15.8M | Buy |
+148,938
| New | +$17.3M | 0.04% | 362 |
|
|
2016
Q3 | – | Sell |
-70,864
| Closed | -$8.28M | – | 1663 |
|
|
2016
Q2 | $8.28M | Buy |
+70,864
| New | +$8.02M | 0.03% | 471 |
|
|
2014
Q2 | – | Sell |
-119,708
| Closed | -$11M | – | 1206 |
|
|
2014
Q1 | $11M | Buy |
119,708
+62,573
| +110% | +$5.77M | 0.07% | 265 |
|
|
2013
Q4 | $5.17M | Buy |
57,135
+21,646
| +61% | +$1.87M | 0.03% | 428 |
|
|
2013
Q3 | $2.83M | Buy |
35,489
+29,739
| +517% | +$2.34M | 0.02% | 486 |
|
|
2013
Q2 | $418K | Buy |
+5,750
| New | +$430K | ﹤0.01% | 654 |
|
Other funds holding ZBH
VCM
VPM
Arrowstreet Capital's ZBH Position: Q1 2026 in Review
Arrowstreet Capital increased its Zimmer Biomet (ZBH) stake by 63% in Q1 2026, buying an estimated $39M and bringing the position to 1,104,218 shares worth $99.8M. The position accounts for 0.05% of the portfolio, ranked #309.
Arrowstreet Capital first reported a position in ZBH in Q2 2013 and has held it in 30 quarters since. The position peaked at $213M in Q2 2023. 913 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Arrowstreet Capital held 1,104,218 shares of Zimmer Biomet worth $99.8M as of Q1 2026.
- Arrowstreet Capital bought 425,349 Zimmer Biomet shares in Q1 2026, an estimated $39M.
- Zimmer Biomet made up 0.05% of Arrowstreet Capital's portfolio in Q1 2026, its #309 holding.
- Arrowstreet Capital first reported a position in Zimmer Biomet in Q2 2013 and has held it in 30 quarters since.
- Arrowstreet Capital's Zimmer Biomet position peaked at $213M in Q2 2023.
- 913 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.